Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- IBI3014Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Unresectable Locally Advanced or Metastatic Solid Tumors
- IBI305Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · EGFR Mutant NSCLC and Platinum Resistant Ovarian Cancer
- IBI334Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Advanced Solid Tumors
- IBR854Phase 21 trial
Imbioray (Hangzhou) Biomedicine Co., Ltd. · Renal Cell Carcinoma (RCC)
- ICP-192Phase 21 trial
Beijing InnoCare Pharma Tech Co., Ltd. · Intrahepatic Cholangiocarcinoma (ICC)
- ICT01Phase 21 trial
ImCheck Therapeutics, an Ipsen company · Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer
- IDE161Phase 21 trial
IDEAYA Biosciences · Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3
- IDE397Phase 21 trial
Amgen · MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors
- IDE849Phase 21 trial
IDEAYA Biosciences · Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3
- IDP-001Phase 21 trial
InduPro, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Head and Neck Squamous Cell Carcinoma
- IDP-023Phase 21 trial
Indapta Therapeutics, INC. · NHL, Multiple Myeloma, Blood Cancer
- IDX-1197Phase 21 trial
Idience Co., Ltd. · Gastric Cancer
- ILKN421HPhase 21 trial
iLeukon Therapeutics, Inc. · Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- IMA401Phase 21 trial
Immatics Biotechnologies GmbH · Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult
- IMA402Phase 21 trial
Immatics Biotechnologies GmbH · Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult
- IMGN151Phase 21 trial
AbbVie · Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer, Fallopian Tube Cancer
- ImofinostatABT-301, MPT0E028Phase 21 trial
Anbogen Therapeutics, Inc. · Colorectal Cancer (Diagnosis), Colorectal Cancer Metastatic, Colorectal Cancer (CRC)
- IMP1734Phase 21 trial
Eikon Therapeutics · Advanced Solid Tumor
- IMP9064Phase 21 trial
Impact Therapeutics, Inc. · Solid Tumor, Advanced Solid Tumor
- IMT-009Phase 21 trial
Immunitas Therapeutics · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer
- INB301Phase 21 trial
Yunnan Baiyao Group Co., Ltd. · Cancer Cachexia
- INBRX-109Phase 21 trial
Inhibrx Biosciences, Inc · Conventional Chondrosarcoma
- INV-6452Phase 21 trial
Shenzhen Ionova Life Sciences Co., Ltd. · Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer
- INV-8989Phase 21 trial
Shenzhen Ionova Life Sciences Co., Ltd. · Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC
- INV-9956Phase 21 trial
Shenzhen Ionova Life Sciences Co., Ltd. · Advanced Metastatic Castration Resistant Prostate Cancer
- INX-315Phase 21 trial
Incyclix Bio · Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor
- IO-108Phase 21 trial
Roche (Genentech) · Advanced Liver Cancers
- IOV-3001Phase 21 trial
Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Ocular Melanoma
- IOV-4001Phase 21 trial
Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Stage III Non-small Cell Lung Cancer
- IOV-5001Phase 21 trial
Iovance Biotherapeutics, Inc. · Advanced Solid Tumors, Non-Small Cell Lung Cancer, Triple Negative Breast Cancer (TNBC)
- IPG1094Phase 21 trial
Nanjing Immunophage Biotech Co., Ltd · Solid Tumor
- IPH5201Phase 21 trial
Innate Pharma · Non Small Cell Lung Cancer
- IPN01194Phase 21 trial
Ipsen · Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma
- IPN01195Phase 21 trial
Ipsen · Advanced Solid Tumor
- IPN01203Phase 21 trial
Ipsen · Advanced Solid Tumor, Metastatic Solid Tumor
- IPN60300Phase 21 trial
Ipsen · Locally Advanced Solid Tumor, Metastatic Solid Tumor
- IPN60350Phase 21 trial
Ipsen · Neoplasms, Neoplasm Metastasis, Neoplastic Processes
- ISM3412Phase 21 trial
InSilico Medicine Hong Kong Limited · Locally Advanced/Metastatic Solid Tumors
- ISM6331Phase 21 trial
InSilico Medicine Hong Kong Limited · Malignant Mesothelioma, Metastatic Malignant Solid Tumor, Advanced Solid Tumor
- IvaltinostatPhase 21 trial
CG Pharmaceuticals, Inc · Metastatic Pancreatic Adenocarcinoma
- JAB-2485Aurora A inhibitorPhase 21 trial
Jacobio Pharmaceuticals Co., Ltd. · Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC
- JAB-30355Phase 21 trial
Jacobio Pharmaceuticals Co., Ltd. · Solid Tumors
- JB100Phase 21 trial
EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma
- JBI-778Phase 21 trial
Jubilant Therapeutics Inc. · Brain Metastases From Solid Tumors, Leptomeningeal Disease, High Grade Glioma (HGG)
- JK06Phase 21 trial
Salubris Biotherapeutics Inc · Solid Tumor
- JL15003InjectionPhase 21 trial
Jecho Biopharmaceuticals Co., Ltd. · Recurrent Glioblastoma Multiforme(GBM)
- JMBI-001Phase 21 trial
Chengdu Anticancer Bioscience, Ltd. · Advance Solid Tumors, Lymphoma, Non-Hodgkin
- JMT203Phase 21 trial
Shanghai JMT-Bio Inc. · Non Small Cell Lung Cancer, Pancreatic Cancer, Cancer Cachexia
- JYP0015Phase 21 trial
Guangzhou JOYO Pharma Co., Ltd · Solid Tumor, Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC)
- KAND567FractalkinePhase 21 trial
Novakand Pharma AB · Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.